SCHEMBL31545367

SCHEMBL31545367

CCOc1ccc(CC(C)NC(C)C(C)=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACACB O00763 20/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13821991 0.81 CYP1A2 (0.58) ACACB
SCHEMBL13821993 0.81 CYP1A2 (0.58) ACACB
SCHEMBL18494260 0.79 ACACB (0.54) ACACB
SCHEMBL255808 0.78 ACACB (0.80) ACACB
SCHEMBL12001479 0.78 ACACB (0.80) ACACB
SCHEMBL6865304 0.76 ACACB (0.54) ACACB
SCHEMBL14355744 0.76 ACACB (0.54) ACACB
SCHEMBL10187732 0.76 ACACB (1.00) ACACB
SCHEMBL164279 0.76 ACACB (1.00) ACACB
SCHEMBL15699361 0.76 ACACB (0.56) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
Send feedback